Spegra Tablet 30’s

Spegra Tablet combines Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate, used primarily for the treatment of HIV-1 infection. This antiretroviral therapy (ART) helps reduce the viral load in the bloodstream, allowing the immune system to remain stronger and preventing further complications associated with HIV. Spegra is prescribed as a part of a comprehensive HIV management plan to improve quality of life and prolong health in HIV-positive individuals.

Uses:

• Effective for managing and treating HIV-1 infection
• Reduces the viral load in the body, helping to control HIV progression

Side Effects:

• Common side effects include headache, nausea, dizziness, and tiredness.
• Rare side effects may include mood changes, liver complications, or skin reactions. Consult a healthcare provider for unusual symptoms.

Key Features:

• Contains Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate for effective HIV-1 control
• Reduces viral load and supports immune health
• Part of a comprehensive HIV management strategy

References:

• Descovy 200 mg/25 mg film coated tablets – Summary of Product Characteristics (SmPC) – (emc). www.medicines.org.uk. Published April 2022. Accessed May 22, 2023. https://www.medicines.org.uk/emc/product/2108/smpc
• Emtricitabine / Tenofovir Alafenamide – Patient | NIH. clinicalinfo.hiv.gov. Published [February 27, 2023]. [Accessed May 22, 2023]. https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-tenofovir-alafenamide/patient#dr1
• KD Tripathi, Antiviral Drugs (Anti-retrovirus), Essentials of Medical Pharmacology, 8th Edition, 2019, 860-872.
• Gilead Sciences, Inc., US Food & Drug Administration, [Revised on Sep 2017] [Accessed on 22th Aug 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208215s005lbl.pdf